These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1128 related articles for article (PubMed ID: 6781947)

  • 21. Chemical modification of lysine residues in affinity purified mushroom tyrosinase.
    Khan IA; Ali R
    Indian J Biochem Biophys; 1987 Feb; 24(1):12-7. PubMed ID: 3114128
    [No Abstract]   [Full Text] [Related]  

  • 22. Electrophoretic characterization of tyrosinase in the coated vesicles of malignant melanoma.
    Mojamdar M; Imokawa G; Mishima Y
    J Dermatol; 1979 Feb; 6(1):5-8. PubMed ID: 110860
    [No Abstract]   [Full Text] [Related]  

  • 23. An animal model for the survival of tyrosinase isozymes in serum.
    Vachtenheim J; Duchon J; Matous B
    Arch Dermatol Res; 1984; 276(2):111-4. PubMed ID: 6426408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammalian tyrosinase: isolation by a simple new procedure and characterization of its steric requirements for cofactor activity.
    Hearing VJ; Ekel TM; Montague PM; Hearing ED; Nicholson JM
    Arch Biochem Biophys; 1978 Jan; 185(2):407-18. PubMed ID: 415664
    [No Abstract]   [Full Text] [Related]  

  • 25. Purification and isoelectric heterogeneity of chicken tyrosinase.
    Yamamoto H; Brumbaugh JA
    Biochim Biophys Acta; 1984 Aug; 800(3):282-90. PubMed ID: 6432056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Half-lives of tyrosinase isozymes from Harding-Passey mouse melanoma.
    Martinez JH; Solano F; Peñafiel R; Lozano JA
    Cancer Lett; 1988 Jan; 38(3):339-46. PubMed ID: 3127037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells.
    McEwan M; Parsons PG; Moss DJ
    J Invest Dermatol; 1988 Apr; 90(4):515-9. PubMed ID: 3127479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of human skin tyrosinase and its protein inhibitor: properties of the enzyme and the mechanism of inhibition by protein.
    Vijayan E; Husain I; Ramaiah A; Madan NC
    Arch Biochem Biophys; 1982 Sep; 217(2):738-47. PubMed ID: 6814365
    [No Abstract]   [Full Text] [Related]  

  • 29. [Heterogeneity of tyrosinases isolated from rat skin, normal human skin, and human melanoma tumors].
    Sukhanov VA; D'iakov VL; Lalaev VV; Iakh''iaev AV
    Biokhimiia; 1991 Jun; 56(6):1026-35. PubMed ID: 1932336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion of particulate tyrosinase to soluble form and to desialylated tyrosinase in human malignant melanoma.
    Nishioka K
    FEBS Lett; 1977 Aug; 80(1):225-8. PubMed ID: 408193
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantitative analysis of mouse tyrosinase by enzyme-linked immunosorbent assay.
    Ishiguro S; Yamamoto H; Yanai N; Takeuchi T
    J Biochem; 1986 Apr; 99(4):1081-5. PubMed ID: 3086301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammalian tyrosinase. Structural and functional interraltionship of isozymes.
    Hearing VJ; Nicholson JM; Montague PM; Ekel TM; Tomecki KJ
    Biochim Biophys Acta; 1978 Feb; 522(2):327-39. PubMed ID: 414782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrosinase activity in serum from patients with malignant melanoma.
    Agrup P; Carstam R; Wittbjer A; Rorsman H; Rosengren E
    Acta Derm Venereol; 1989; 69(2):120-4. PubMed ID: 2564228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional analysis of tyrosinase isozymes of cultured malignant melanoma cells during the recovery period following interrupted melanogenesis induced by glycosylation inhibitors.
    Imokawa G; Mishima Y
    J Invest Dermatol; 1984 Sep; 83(3):196-201. PubMed ID: 6432920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Particulate nature of o-diphenoloxidase in Mycobacterium leprae and assay of the enzyme by the radioisotope technique.
    Prabhakaran K; Harris EB; Kirchheimer WF
    Microbios; 1973; 8(30):151-7. PubMed ID: 4204390
    [No Abstract]   [Full Text] [Related]  

  • 36. Tyrosinase activity and isoenzyme distribution corresponding to growth and regression of melanoma in Sinclair miniature swine.
    Kovacs SA; Geekie KM; Oxenhandler RW; Agris PF
    J Natl Cancer Inst; 1981 Sep; 67(3):645-51. PubMed ID: 6792414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of human tyrosinase by cysteine. Protection by dopa and tyrosine.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1984; 64(2):155-7. PubMed ID: 6203305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.
    Miranda M; Botti D
    Gen Pharmacol; 1983; 14(2):231-7. PubMed ID: 6404691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro effects of melanocytolytic agents and other compounds upon dominant human melanoma tyrosinase activity.
    Chen YM; Chavin W
    Experientia; 1978 Jan; 34(1):21-2. PubMed ID: 413735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The involvement of histidine at the active site of Harding-Passey mouse melanoma tyrosinase.
    Martínez JH; Solano F; García-Borrón JC; Iborra JL; Lozano JA
    Biochem Int; 1985 Nov; 11(5):729-38. PubMed ID: 3937527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.